1. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice—i. morphology, quantitation, tissue distribution (reprinted from j exp med, vol 137, pg 1142-1162, 1973. J Immunol. 2007;178:5–25.
2. Constantino J, Gomes C, Falcao A, Cruz MT, Neves BM. Antitumor dendritic cell-based vaccines: lessons from 20 years of clinical trials and future perspectives. Transl Res. 2016;168:74–95.
3. Gu X, Erb U, Büchler MW, Zöller M. Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice. Int J Cancer. 2015;136:E74–84.
4. Lasky JL, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB. Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Res. 2013;33:2047–56.
5. Rainone V, Martelli C, Ottobrini L, Biasin M, Texido G, Degrassi A, Borelli M, Lucignani G, Trabattoni D, Clerici M: Immunological characterization of whole tumour lysate-loaded dendritic cells for cancer immunotherapy (vol 1, e0146622, 2016). Plos One 2016;11